Evidence map›Paper›PMID 30818968›Full record

ArticleASN neuro

Subacute Transplantation of Native and Genetically Engineered Neural Progenitors Seeded on Microsphere Scaffolds Promote Repair and Functional Recovery After Traumatic Brain Injury.

Nolan B Skop, Sweta Singh, Henri Antikainen, Chaitali Saqcena, Frances Calderon, Deborah E Rothbard, Cheul H Cho, Chirag D Gandhi, Steven W Levison, Radek Dobrowolski

Open access · goldAbstract read
In one paragraph

Article in ASN neuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Nolan B Skop1 Department of Pharmacology, Physiology and Neuroscience, New Jersey Medical School, Newark, NJ, USA.
Sweta Singh3 Department of Biological Sciences, Rutgers University, Newark, NJ, USA.
Henri Antikainen3 Department of Biological Sciences, Rutgers University, Newark, NJ, USA.
Chaitali Saqcena3 Department of Biological Sciences, Rutgers University, Newark, NJ, USA.
Frances Calderon1 Department of Pharmacology, Physiology and Neuroscience, New Jersey Medical School, Newark, NJ, USA.
Deborah E Rothbard1 Department of Pharmacology, Physiology and Neuroscience, New Jersey Medical School, Newark, NJ, USA.
Cheul H Cho2 Department of Biomedical Engineering, New Jersey Institute of Technology, Newark, NJ, USA.
Chirag D Gandhi5 Department of Neurosurgery, Westchester Medical Center at NY Medical College, Valhalla, NY, USA.
Steven W Levison1 Department of Pharmacology, Physiology and Neuroscience, New Jersey Medical School, Newark, NJ, USA.
Radek Dobrowolski3 Department of Biological Sciences, Rutgers University, Newark, NJ, USA.
Rutgers, The State University of New Jersey · USNew Jersey Institute of Technology · USRutgers New Jersey Medical SchoolWestchester Medical Center · US

Funding

Engineering Multifunctional Microspheres for Brain Injury RepairR15NS087501 · NINDS · NEW JERSEY INSTITUTE OF TECHNOLOGY · PI CHO, CHEUL H · 2014 to 2014
$412k
NINDS NIH HHS R15 NS087501
6 · The paper itself

Abstract

There is intense interest and effort toward regenerating the brain after severe injury. Stem cell transplantation after insult to the central nervous system has been regarded as the most promising approach for repair; however, engrafting cells alone might not be sufficient for effective regeneration. In this study, we have compared neural progenitors (NPs) from the fetal ventricular zone (VZ), the postnatal subventricular zone, and an immortalized radial glia (RG) cell line engineered to conditionally secrete the trophic factor insulin-like growth factor 1 (IGF-1). Upon differentiation in vitro, the VZ cells were able to generate a greater number of neurons than subventricular zone cells. Furthermore, differentiated VZ cells generated pyramidal neurons . In vitro, doxycycline-driven secretion of IGF-1 strongly promoted neuronal differentiation of cells with hippocampal, interneuron and cortical specificity. Accordingly, VZ and engineered RG-IGF-1-hemagglutinin (HA) cells were selected for subsequent in vivo experiments. To increase cell survival, we delivered the NPs attached to a multifunctional chitosan-based scaffold. The microspheres containing adherent NPs were injected subacutely into the lesion cavity of adult rat brains that had sustained controlled cortical impact injury. At 2 weeks posttransplantation, the exogenously introduced cells showed a reduction in stem cell or progenitor markers and acquired mature neuronal and glial markers. In beam walking tests assessing sensorimotor recovery, transplanted RG cells secreting IGF-1 contributed significantly to functional improvement while native VZ or RG cells did not promote significant recovery. Altogether, these results support the therapeutic potential of chitosan-based multifunctional microsphere scaffolds seeded with genetically modified NPs expressing IGF-1 to promote repair and functional recovery after traumatic brain injuries.

Indexed as

MicrospheresTissue ScaffoldsAnimalsBrainBrain Injuries, TraumaticCell LineChitosanDisease Models, AnimalEpendymoglial CellsGenetic EngineeringInsulin-Like Growth Factor IMaleNerve RegenerationNeural Stem CellsNeurogenesisRats, Sprague-DawleyChitosanInsulin-Like Growth Factor Icell transplantationfibroblast growth factorfibronectininsulin-like growth factor 1multifunctional scaffoldneural stem cellsneurotraumaradial gliaregenerationregenerative medicine

Identifiers

PMID30818968
PMCPMC6399762
OpenAlexW2918531946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.